98 related articles for article (PubMed ID: 25521353)
21. From cancer genomics to precision oncology--tissue's still an issue.
Cohen RL; Settleman J
Cell; 2014 Jun; 157(7):1509-14. PubMed ID: 24949964
[TBL] [Abstract][Full Text] [Related]
22. Genomic and molecular aberrations in malignant peripheral nerve sheath tumor and their roles in personalized target therapy.
Yang J; Du X
Surg Oncol; 2013 Sep; 22(3):e53-7. PubMed ID: 23830351
[TBL] [Abstract][Full Text] [Related]
23. Targeted therapies of solid cancers: new options, new challenges.
Awada A; Aftimos PG
Curr Opin Oncol; 2013 May; 25(3):296-304. PubMed ID: 23493191
[TBL] [Abstract][Full Text] [Related]
24. Radiogenomics offers promise of personalized radiation cancer therapy.
Becze E
ONS Connect; 2014 Jun; 29(2):38-9. PubMed ID: 24961042
[No Abstract] [Full Text] [Related]
25. From next-generation sequencing to nanopore sequencing technology: paving the way to personalized genomic medicine.
Ku CS; Roukos DH
Expert Rev Med Devices; 2013 Jan; 10(1):1-6. PubMed ID: 23278216
[No Abstract] [Full Text] [Related]
26. Personalized medicine in oncology: tailoring the right drug to the right patient.
Jiang Y; Wang M
Biomark Med; 2010 Aug; 4(4):523-33. PubMed ID: 20701441
[TBL] [Abstract][Full Text] [Related]
27. Genomic strategies for personalized cancer therapy.
Garman KS; Nevins JR; Potti A
Hum Mol Genet; 2007 Oct; 16 Spec No. 2():R226-32. PubMed ID: 17911165
[TBL] [Abstract][Full Text] [Related]
28. Clinical cancer genome and precision medicine.
Roukos DH; Ku CS
Ann Surg Oncol; 2012 Nov; 19(12):3646-50. PubMed ID: 22851046
[TBL] [Abstract][Full Text] [Related]
29. From genomic landscapes to personalized cancer management-is there a roadmap?
Swanton C; Caldas C
Ann N Y Acad Sci; 2010 Oct; 1210():34-44. PubMed ID: 20973797
[TBL] [Abstract][Full Text] [Related]
30. Personalized treatments of cancer patients: a reality in daily practice, a costly dream or a shared vision of the future from the oncology community?
Arnedos M; Soria JC; Andre F; Tursz T
Cancer Treat Rev; 2014 Dec; 40(10):1192-8. PubMed ID: 25441102
[TBL] [Abstract][Full Text] [Related]
31. Radiogenomics: the promise of personalized treatment in radiation oncology?
Proud C
Clin J Oncol Nurs; 2014 Apr; 18(2):185-9. PubMed ID: 24675253
[TBL] [Abstract][Full Text] [Related]
32. A heuristic algorithm solving the mutual-exclusivity-sorting problem.
Vinceti A; Trastulla L; Perron U; Raiconi A; Iorio F
Bioinformatics; 2023 Jan; 39(1):. PubMed ID: 36669133
[TBL] [Abstract][Full Text] [Related]
33. [Intraclonal heterogeneity in tumors and its impact on precision medicine].
Roux J; Gouzé JL; Hofman P
Med Sci (Paris); 2015 Jan; 31(1):28-31. PubMed ID: 25658727
[No Abstract] [Full Text] [Related]
34. Integrating germline and somatic data towards a personalized cancer medicine.
Pujana MA
Trends Mol Med; 2014 Aug; 20(8):413-5. PubMed ID: 25086750
[TBL] [Abstract][Full Text] [Related]
35. Personalized medicine benefits patients in early trials: matching targeted therapies with gene mutations is associated with better outcomes, even in phase 1 studies.
Printz C
Cancer; 2012 Oct; 118(20):4911-2. PubMed ID: 23042614
[No Abstract] [Full Text] [Related]
36. [Personalized medicine and molecular targets of drugs].
Nishiyama M
Nihon Rinsho; 2010 Oct; 68(10):1917-22. PubMed ID: 20954340
[TBL] [Abstract][Full Text] [Related]
37. Translational medicine promising personalized therapy in oncology.
Zeng YX; Zhang XS; Liu Q
Front Med China; 2010 Dec; 4(4):351-5. PubMed ID: 21107749
[No Abstract] [Full Text] [Related]
38. [Genome sequencing for personalized cancer treatment].
Skotheim RI; Meza-Zepeda LA; Hovig E; Lønning PE; Lothe RA; Myklebost O
Tidsskr Nor Laegeforen; 2012 Nov; 132(21):2406-8. PubMed ID: 23160594
[No Abstract] [Full Text] [Related]
39. Hotspot oncomutations: implications for personalized cancer treatment.
Myers MB; Wang Y; McKim KL; Parsons BL
Expert Rev Mol Diagn; 2012 Jul; 12(6):603-20. PubMed ID: 22845481
[TBL] [Abstract][Full Text] [Related]
40. Fast mutual exclusivity algorithm nominates potential synthetic lethal gene pairs through brute force matrix product computations.
Fedrizzi T; Ciani Y; Lorenzin F; Cantore T; Gasperini P; Demichelis F
Comput Struct Biotechnol J; 2021; 19():4394-4403. PubMed ID: 34429855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
